Abstract
Our current study provided a comprehensive profile regarding the mtDNA variation and background of Chinese patients with LHON and m.14484T>C. Matrilineal background might affect the expression of LHON in Chinese patients with m.14484T>C.
Introduction
Leber hereditary optic neuropathy (LHON) is a mitochondrial genetic disorder characterized by sudden, painless vision loss, typically affecting young men. While three primary mitochondrial DNA (mtDNA) mutations—m.11778G>A, m.3460G>A, and m.14484T>C—are known to cause the disease, they exhibit incomplete penetrance. This means that many individuals carrying these mutations never develop clinical symptoms.
The central challenge in LHON research is identifying the "modifiers"—environmental factors, nuclear genes, or the specific mtDNA background (haplogroup)—that trigger vision loss. While these factors have been studied extensively in European populations, there has been a significant data gap regarding Chinese patients carrying the m.14484T>C mutation. This study aims to characterize the mtDNA variation and haplogroup distribution in this specific population to identify potential genetic modifiers.
Methods
Researchers screened a large cohort of 1,626 suspected LHON patients to identify 52 individuals (from 14 families and 38 sporadic cases) harboring the m.14484T>C mutation. The investigation involved:
- Complete mtDNA Sequencing: The entire mitochondrial genome (16,569 base pairs) was sequenced for 11 probands to identify potential "secondary" pathogenic mutations.
- Haplogroup Classification: Control-region sequences of all 52 patients were analyzed to categorize them into specific East Asian haplogroups (e.g., A, B, C, D, F, G).
- Phylogenetic Analysis: Evolutionary relationships were reconstructed using the revised Cambridge Reference Sequence (rCRS) and the PhyloTree database.
- Statistical Comparison: Haplogroup distributions in the patient group were compared against a reference dataset of 408 Han Chinese individuals from the general population to identify statistically significant differences.
Results
Absence of Secondary Pathogenic Mutations
Full sequencing of 11 mitochondrial genomes revealed no novel, clearly pathogenic mutations co-segregating with the disease. This suggests that clinical outcomes are likely driven by the cumulative effect of common variants within a haplogroup rather than a single additional deleterious mutation.
The Role of Haplogroups as Modifiers
The study identified significant associations between specific mitochondrial lineages and disease risk:
- Protective Effect of Haplogroup F: There was a strikingly lower prevalence of haplogroup F in LHON patients (1.9%) compared to the general population (16.7%). This suggests that the genetic background of the F lineage may buffer the effects of the m.14484T>C mutation ($P = 0.003$, Odds Ratio = 0.098).
- Increased Risk Lineages: Conversely, haplogroups C, G, M10, and Y were significantly overrepresented in the patient group. Haplogroup C, in particular, showed a strong association with increased susceptibility ($P = 0.002$, Odds Ratio = 5.614).
Demographic and Genetic Trends
- Prevalence: The m.14484T>C mutation was found in 9.7% of the Chinese LHON cohort, a lower frequency than the ~21% typically observed in European patients.
- Gender Bias: The study confirmed a strong male bias, with an affected male-to-female ratio of 5.2:1.
- Heteroplasmy: Only 5.8% of the Chinese patients showed heteroplasmy (a mix of healthy and mutated mtDNA), which is significantly lower than the ~36% reported in European studies.
Discussion
The findings highlight that LHON modifiers are continent-specific. In European populations, haplogroup J is the primary risk-increaser; however, in this Chinese cohort, the risk and protective profiles are entirely different. This emphasizes the necessity for population-specific genetic counseling and risk assessment.
Conclusion
This study provides a comprehensive profile of the mtDNA background in Chinese patients with the m.14484T>C mutation, demonstrating that matrilineal background significantly influences the expression of LHON. Future work should focus on functional validation to determine how variants in haplogroup F protect mitochondrial function and how these mtDNA backgrounds interact with the nuclear genome.
Summary updated